Trial Profile
A single-center safety and tolerability study to evaluate the impact of treatment interruption on re-initiation of bifeprunox in subjects with schizophrenia or schizoaffective disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jan 2015
Price :
$35
*
At a glance
- Drugs Bifeprunox (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- Sponsors Solvay
- 30 Dec 2005 New trial record.